Largest phase 3 trial of novel treatment for hypertension shows promising results Dr. Kamal Kant Kohli28 May 2025 8:30 PM ISTThe data from the Launch-HTN trial, announced at the 34th European Meeting on Hypertension and Cardiovascular Protection, show that lorundrostat, an...
Lorundrostat Significantly Lowers Blood Pressure in Resistant Hypertension: Study Medha Baranwal1 May 2025 9:00 AM ISTUSA: A recent clinical trial has shown that Lorundrostat, a novel aldosterone synthase inhibitor, significantly lowers blood pressure in patients with...
Lorundrostat lowers blood pressure compared with placebo at 12 weeks, suggests research Dr. Kamal Kant Kohli2 April 2025 9:00 PM ISTAmong patients with uncontrolled hypertension, the investigational drug lorundrostat brought a significant reduction in blood pressure at 12 weeks...
Lorundrostat Shows Promise in Treatment of Uncontrolled and Resistant Hypertension in trials Dr. Kamal Kant Kohli21 March 2025 9:00 AM ISTLorundrostat demonstrated strong efficacy and safety in the pivotal Phase 3 Launch-HTN and Phase 2 Advance-HTN trials. These studies evaluated the...
Lorundrostat effective for lowering BP among patients with uncontrolled hypertension: JAMA Dr. Kamal Kant Kohli12 Sept 2023 9:30 AM ISTUSA: Aldosterone synthase inhibition with lorundrostat is effective at lowering blood pressure (BP) compared with placebo among patients with...
